Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, November 15, 2019
PredictImmune announced James Clark as Chief Technology Officer.
read more
Theravance Biopharma and SciClone Pharmaceuticals have entered into a development and commercialization agreement granting SciClone exclusive development and commercial rights for the antibiotic VIBATIV® (telavancin) in China and certain adjacent ...
read more
STA Pharmaceutical announced its ASU in Shanghai and API process R&D and manufacturing facility in Changzhou, have successfully passed two inspections from the FDA.
read more
Wednesday, November 06, 2019
Cytel has acquired MTEK Sciences to further expand its advanced real-world analytics (RWA) capabilities.
read more
Charles River Laboratories International Inc. announced a long-term solar energy contract to address the entirety of the Company’s North American electric power requirements with clean, renewable energy by 2023. Charles River and Duke Energy ...
read more
Tuesday, December 14, 2021
CellCarta, a global provider of precision medicine laboratory services, announced the acquisition of Biogazelle ("Biogazelle"), a leader in genomic testing solutions. Located in Ghent (Belgium), Biogazelle develops and deploys high-end digital PCR (...
read more
ICIG announced today changes in the management of CordenPharma, its pharmaceutical contract manufacturing business.
read more
Tuesday, December 02, 2025
eXmoor Pharma and the Translational Research Office (TRO) at University College London (UCL) have formed a strategic collaboration to accelerate the development of novel cell and gene therapies (CGTs) from academic research into clinical application.
read more
Friday, September 11, 2020
Direct Biologics will leverage Bioclinica's Interactive Response Technology (IRT) for their EXIT COVID-19 study.
read more
Thursday, September 06, 2018
Synthetic Biologics has entered into an agreement with Cedars-Sinai Medical Center for an investigator-sponsored Phase 2 clinical study of SYN-010.
read more
US Bioservices has announced findings from an initial program with AdhereTech.
read more
Catalent announced the appointment of Sridhar Krishnan, to the newly created position of Vice President, The Catalent Way.
read more
Sunday, September 18, 2016
Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO Stephen J. Ubl issued the following statement on the release of the Biosimilar User Fee Act (II) performance goals letter.
read more
Tuesday, December 12, 2017
Aldevron announced a license agreement whereby Aldevron will manufacture and distribute a S. pyogenes Cas9 variant which is patented by IDT.
read more
Tuesday, November 19, 2024
Matica Biotechnology, Inc. announced the appointment of Min Park, MBA as Chief Commercial Officer.
read more